These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26981952)

  • 1. Investor Outlook: After the Biotech Bubble Popped.
    Schimmer J; Breazzano S; Yang J
    Hum Gene Ther Clin Dev; 2016 Mar; 27(1):19-26. PubMed ID: 26981952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investor Outlook: Focus on Upcoming LCA2 Gene Therapy Phase III Results.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):144-9. PubMed ID: 26390089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investor Outlook: Gene Therapy Picking up Steam; At a Crossroads.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2016 Sep; 27(3):87-92. PubMed ID: 27632771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investor malaise stalks UK, European biotech.
    Mitchell P
    Nat Biotechnol; 2008 Mar; 26(3):256-7. PubMed ID: 18327222
    [No Abstract]   [Full Text] [Related]  

  • 5. Investor Outlook: The Unanswered Questions.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2017 Jun; 28(2):57-61. PubMed ID: 28537450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing long-term value creation after biotech and non-biotech IPOs, 1997-2016.
    Cleary EG; McNamee LM; de Boer S; Holden J; Fitzgerald L; Ledley FD
    PLoS One; 2021; 16(1):e0243813. PubMed ID: 33406113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investor Outlook: Solving Gene Therapy Pricing…with a Cures Voucher?
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2016 Dec; 27(4):132-136. PubMed ID: 27983892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investor volatility plagues drug companies on new Chinese exchange.
    Mitchell P; Jing F
    Nat Biotechnol; 2010 Jan; 28(1):9-10. PubMed ID: 20062025
    [No Abstract]   [Full Text] [Related]  

  • 9. Crystal gazing: biotech's financial outlook: the biotech analyst's view.
    Schmidt E
    Nat Biotechnol; 2006 Mar; 24(3):261-2. PubMed ID: 16525376
    [No Abstract]   [Full Text] [Related]  

  • 10. Investor Outlook: Significance of the Positive LCA2 Gene Therapy Phase III Results.
    Schimmer J; Breazzano S
    Hum Gene Ther Clin Dev; 2015 Dec; 26(4):208-10. PubMed ID: 26684444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beware the biotech barker.
    Jacobs T
    Nat Biotechnol; 2005 May; 23(5):538. PubMed ID: 15877065
    [No Abstract]   [Full Text] [Related]  

  • 12. Public biotech 2010--the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2011 Jul; 29(7):585-91. PubMed ID: 21747381
    [No Abstract]   [Full Text] [Related]  

  • 13. Could bank loans solve Europe's biotech financing slump?
    Mitchell P
    Nat Biotechnol; 2005 Dec; 23(12):1459-60. PubMed ID: 16333276
    [No Abstract]   [Full Text] [Related]  

  • 14. UK biotech smashes financing record.
    Nat Biotechnol; 2015 Sep; 33(9):889. PubMed ID: 26348941
    [No Abstract]   [Full Text] [Related]  

  • 15. Pension plans dally with biotech.
    Ransom J
    Nat Biotechnol; 2006 Jun; 24(6):600. PubMed ID: 16763575
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

  • 17. BioXell: an Italian biotech success story?
    Sheridan C
    Nat Biotechnol; 2006 Sep; 24(9):1045-6. PubMed ID: 16964198
    [No Abstract]   [Full Text] [Related]  

  • 18. A special biotech speculation.
    Jacobs T
    Nat Biotechnol; 2006 Jun; 24(6):622. PubMed ID: 16763586
    [No Abstract]   [Full Text] [Related]  

  • 19. Japanese giants renew interest in industrial biotech.
    Sipp D
    Nat Biotechnol; 2005 Mar; 23(3):275-6. PubMed ID: 15765071
    [No Abstract]   [Full Text] [Related]  

  • 20. Biotech venture capital--it's not too late to be early.
    Klausner A
    Nat Biotechnol; 2005 Apr; 23(4):417-8. PubMed ID: 15815662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.